vs
COLLEGIUM PHARMACEUTICAL, INC（COLL）与WSFS FINANCIAL CORP（WSFS）财务数据对比。点击上方公司名可切换其他公司
WSFS FINANCIAL CORP的季度营收约是COLLEGIUM PHARMACEUTICAL, INC的1.3倍（$275.3M vs $205.4M），WSFS FINANCIAL CORP净利率更高（31.5% vs 8.3%，领先23.3%），COLLEGIUM PHARMACEUTICAL, INC同比增速更快（12.9% vs 7.5%），过去两年COLLEGIUM PHARMACEUTICAL, INC的营收复合增速更高（19.1% vs 1.7%）
Collegium制药是一家专科制药企业，专注于研发和商业化具备滥用威慑特性的创新疼痛管理疗法，主要面向美国市场，推出适用于慢性疼痛患者的缓释镇痛产品，服务覆盖基层及专科医疗领域的医护人员。
WSFS金融集团是一家金融服务企业，核心子公司WSFS银行是总部位于特拉华州及大特拉华谷地区规模最大、经营历史最久的本地管理银行与财富管理机构。集团共运营115个网点，其中88个为银行网点，分布在宾夕法尼亚、特拉华、新泽西、佛罗里达、弗吉尼亚、内华达六州，提供全面金融服务。
COLL vs WSFS — 直观对比
营收规模更大
WSFS
是对方的1.3倍
$205.4M
营收增速更快
COLL
高出5.4%
7.5%
净利率更高
WSFS
高出23.3%
8.3%
两年增速更快
COLL
近两年复合增速
1.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $205.4M | $275.3M |
| 净利润 | $17.0M | $86.8M |
| 毛利率 | 62.5% | — |
| 营业利润率 | 29.6% | — |
| 净利率 | 8.3% | 31.5% |
| 营收同比 | 12.9% | 7.5% |
| 净利润同比 | 35.3% | 31.7% |
| 每股收益（稀释后） | $0.48 | $1.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COLLWSFS
| Q1 26 | — | $275.3M | ||
| Q4 25 | $205.4M | $271.9M | ||
| Q3 25 | $209.4M | $270.5M | ||
| Q2 25 | $188.0M | $267.5M | ||
| Q1 25 | $177.8M | $256.1M | ||
| Q4 24 | $181.9M | $261.5M | ||
| Q3 24 | $159.3M | $267.7M | ||
| Q2 24 | $145.3M | $266.0M |
净利润COLLWSFS
| Q1 26 | — | $86.8M | ||
| Q4 25 | $17.0M | $72.7M | ||
| Q3 25 | $31.5M | $76.4M | ||
| Q2 25 | $12.0M | $72.3M | ||
| Q1 25 | $2.4M | $65.9M | ||
| Q4 24 | $12.5M | $64.2M | ||
| Q3 24 | $9.3M | $64.4M | ||
| Q2 24 | $19.6M | $69.3M |
毛利率COLLWSFS
| Q1 26 | — | — | ||
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — |
营业利润率COLLWSFS
| Q1 26 | — | — | ||
| Q4 25 | 29.6% | 35.8% | ||
| Q3 25 | 29.7% | 37.3% | ||
| Q2 25 | 18.7% | 35.7% | ||
| Q1 25 | 12.2% | 34.0% | ||
| Q4 24 | 20.9% | 32.3% | ||
| Q3 24 | 21.9% | 31.9% | ||
| Q2 24 | 32.7% | 34.0% |
净利率COLLWSFS
| Q1 26 | — | 31.5% | ||
| Q4 25 | 8.3% | 26.7% | ||
| Q3 25 | 15.0% | 28.3% | ||
| Q2 25 | 6.4% | 27.0% | ||
| Q1 25 | 1.4% | 25.7% | ||
| Q4 24 | 6.9% | 24.6% | ||
| Q3 24 | 5.9% | 24.1% | ||
| Q2 24 | 13.5% | 26.0% |
每股收益（稀释后）COLLWSFS
| Q1 26 | — | $1.64 | ||
| Q4 25 | $0.48 | $1.33 | ||
| Q3 25 | $0.84 | $1.37 | ||
| Q2 25 | $0.34 | $1.27 | ||
| Q1 25 | $0.07 | $1.12 | ||
| Q4 24 | $0.36 | $1.08 | ||
| Q3 24 | $0.27 | $1.08 | ||
| Q2 24 | $0.52 | $1.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $386.7M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $301.7M | $2.7B |
| 总资产 | $1.7B | $22.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资COLLWSFS
| Q1 26 | — | — | ||
| Q4 25 | $386.7M | $1.7B | ||
| Q3 25 | $285.9M | — | ||
| Q2 25 | $222.2M | — | ||
| Q1 25 | $197.8M | — | ||
| Q4 24 | $162.8M | $1.2B | ||
| Q3 24 | $120.0M | — | ||
| Q2 24 | $271.6M | — |
股东权益COLLWSFS
| Q1 26 | — | $2.7B | ||
| Q4 25 | $301.7M | $2.7B | ||
| Q3 25 | $274.8M | $2.8B | ||
| Q2 25 | $232.2M | $2.7B | ||
| Q1 25 | $234.4M | $2.7B | ||
| Q4 24 | $228.8M | $2.6B | ||
| Q3 24 | $234.3M | $2.7B | ||
| Q2 24 | $216.6M | $2.5B |
总资产COLLWSFS
| Q1 26 | — | $22.1B | ||
| Q4 25 | $1.7B | $21.3B | ||
| Q3 25 | $1.6B | $20.8B | ||
| Q2 25 | $1.6B | $20.8B | ||
| Q1 25 | $1.6B | $20.5B | ||
| Q4 24 | $1.7B | $20.8B | ||
| Q3 24 | $1.6B | $20.9B | ||
| Q2 24 | $1.1B | $20.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $123.0M | — |
| 自由现金流经营现金流 - 资本支出 | $122.4M | — |
| 自由现金流率自由现金流/营收 | 59.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | 7.25× | — |
| 过去12个月自由现金流最近4个季度 | $327.6M | — |
8季度趋势，按日历期对齐
经营现金流COLLWSFS
| Q1 26 | — | — | ||
| Q4 25 | $123.0M | $220.0M | ||
| Q3 25 | $78.4M | $121.5M | ||
| Q2 25 | $72.4M | $37.2M | ||
| Q1 25 | $55.4M | $8.7M | ||
| Q4 24 | $84.6M | $219.9M | ||
| Q3 24 | $-9.0M | $3.1M | ||
| Q2 24 | $67.4M | $44.8M |
自由现金流COLLWSFS
| Q1 26 | — | — | ||
| Q4 25 | $122.4M | $213.6M | ||
| Q3 25 | $78.3M | $120.3M | ||
| Q2 25 | $72.4M | $35.2M | ||
| Q1 25 | $54.6M | $6.3M | ||
| Q4 24 | $84.1M | $205.6M | ||
| Q3 24 | $-9.2M | $-489.0K | ||
| Q2 24 | $67.1M | $42.1M |
自由现金流率COLLWSFS
| Q1 26 | — | — | ||
| Q4 25 | 59.6% | 78.6% | ||
| Q3 25 | 37.4% | 44.5% | ||
| Q2 25 | 38.5% | 13.2% | ||
| Q1 25 | 30.7% | 2.5% | ||
| Q4 24 | 46.2% | 78.6% | ||
| Q3 24 | -5.8% | -0.2% | ||
| Q2 24 | 46.2% | 15.8% |
资本支出强度COLLWSFS
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 2.3% | ||
| Q3 25 | 0.1% | 0.5% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.4% | 0.9% | ||
| Q4 24 | 0.3% | 5.5% | ||
| Q3 24 | 0.2% | 1.4% | ||
| Q2 24 | 0.2% | 1.0% |
现金转化率COLLWSFS
| Q1 26 | — | — | ||
| Q4 25 | 7.25× | 3.03× | ||
| Q3 25 | 2.49× | 1.59× | ||
| Q2 25 | 6.05× | 0.51× | ||
| Q1 25 | 22.92× | 0.13× | ||
| Q4 24 | 6.75× | 3.43× | ||
| Q3 24 | -0.96× | 0.05× | ||
| Q2 24 | 3.44× | 0.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
